EnBio Holdings Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Yoshikazu Nakamura

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	1.4yrs
Participación del CEO	5.3%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	4.9yrs

Actualizaciones recientes de la dirección

Recent updates

Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

Aug 07

CEO

Yoshikazu Nakamura (51 yo)

1.4yrs

Permanencia

Mr. Yoshikazu Nakamura is Chief Executive Officer, President & Representative Director at EnBio Holdings, Inc. since June 2023. He serves as an Independent Outside Director of Karadanote Inc. since October...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Yoshikazu Nakamura	CEO, President & Representative Director	20.4yrs	sin datos	5.32% ¥ 256.6m
Takahiro Hoshino	Independent Outside Director	1.4yrs	sin datos	0.12% ¥ 5.9m
Minoru Nishimura	Chairman of the Board	16.8yrs	sin datos	6.1% ¥ 294.3m
Tadahide Kameyama	Independent Outside Director	8.4yrs	sin datos	0.0012% ¥ 59.3k
Koichiro Hirata	Independent Outside Director	1.4yrs	sin datos	2.46% ¥ 118.8m
Ichiro Namekawa	Independent Outside Director	1.4yrs	sin datos	0.18% ¥ 8.9m
Toshihito Yamamoto	Director	5.4yrs	sin datos	0.19% ¥ 9.2m
Yukinobu Yokomizo	Director	5.4yrs	sin datos	0.17% ¥ 8.4m
Yuki Odake	Independent Outside Director	4.4yrs	sin datos	0.012% ¥ 594.2k
Kazuo Takayama	Independent Outside Director	1.4yrs	sin datos	sin datos

4.9yrs

Permanencia media

61.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 6092 se considera experimentada (4.9 años de antigüedad promedio).

EnBio Holdings Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

EnBio Holdings, Inc, Annual General Meeting, Jun 26, 2024

Less than half of directors are independent

EnBio Holdings, Inc, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Recent updates

Now 22% undervalued

EnBio Holdings, Inc to Report Q2, 2025 Results on Nov 14, 2024

Now 20% undervalued

First quarter 2025 earnings released: EPS: JP¥43.14 (vs JP¥22.68 in 1Q 2024)

Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

Investor sentiment deteriorates as stock falls 18%

EnBio Holdings, Inc (TSE:6092) announces an Equity Buyback for 60,000 shares, representing 0.74% for ¥35 million.

EnBio Holdings, Inc to Report Q1, 2025 Results on Aug 14, 2024

EnBio Holdings, Inc, Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥8.00 per share

EnBio Holdings Co., Ltd. to Report Fiscal Year 2024 Results on May 14, 2024

Third quarter 2024 earnings released: EPS: JP¥2.95 (vs JP¥17.46 loss in 3Q 2023)

EnBio Holdings Co., Ltd. to Report Q3, 2024 Results on Feb 14, 2024

EnBio Holdings Co., Ltd. to Report Q2, 2024 Results on Nov 14, 2023

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: JP¥22.68 (vs JP¥72.24 in 1Q 2023)

EnBio Holdings, Inc to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment deteriorates as stock falls 18%

EnBio Holdings, Inc announced that it has received ¥1.056 billion in funding from CRE, Inc.

Upcoming dividend of JP¥8.00 per share at 1.1% yield

Third quarter 2023 earnings released: JP¥17.46 loss per share (vs JP¥30.84 profit in 3Q 2022)

EnBio Holdings, Inc to Report Q3, 2023 Results on Feb 13, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: JP¥73.37 (vs JP¥20.38 in 2Q 2022)

Less than half of directors are independent

EnBio Holdings, Inc to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: EPS: JP¥72.24 (vs JP¥36.15 in 1Q 2022)

EnBio Holdings, Inc to Report Q1, 2023 Results on Aug 12, 2022

EnBio Holdings, Inc, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

EnBio Holdings, Inc to Report Fiscal Year 2022 Results on May 13, 2022

EnBio Holdings, Inc Provides Dividend Guidance for the Year Ending March 31, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

EnBio Holdings, Inc (TSE:6092) announces an Equity Buyback for 70,000 shares, representing 1.05% for ¥50 million.

EnBio Holdings, Inc to Report Fiscal Year 2021 Results on May 14, 2021

Third quarter 2021 earnings released: EPS JP¥9.73 (vs JP¥6.39 in 3Q 2020)

EnBio Holdings,Inc to Report Q3, 2021 Results on Feb 12, 2021

New 90-day low: JP¥582

EnBio Holdings,Inc to Report Q2, 2021 Results on Nov 13, 2020

EnBio Holdings,Inc to Report Q1, 2021 Results on Aug 12, 2020

CEO

Permanencia

Miembros de la Junta

Permanencia media

Promedio de edad